multinational company that optimizes clinical trial planning through a structured online feasibility platform . the platform provides tools and analytics to pharmaceutical and biotechnology companies and contract research organizations that transform how locations research centers and investigators are evaluated for inclusion in clinical trials . all the multi dimensional inputs are integrated and made easily accessible through novel visualization methods . at the same time vis enables research centers to create an online profile which answers over 85 percent of questions raised in feasibility assessments . networking tools facilitate communication and engagement between trial planners and centers . the vis platform is transforming the feasibility process using the same web technologies that have transformed the consumer web . vis research inc. type incorporated industry clinical research analytics technology information technology analytics founded new york usa 2010 founder fabio thiers md phd romero tavares headquarters 32 w 86th st new york ny united states number of locations united states brazil germany india area served worldwide key people fabio thiers ceo richard kivel coo gustavo kesselring executive director latam dan martines cio chuck swanson head of sales marc wilenzick head of stakeholder engagement james rosenstein head of global communications johanna schenk executive director europe jatin shah executive director asia products location analytics center analytics analytics services number of employees 50 april 1 2013 slogan the power of online feasibility website www.visresearch.com contents 1 overview 2 technology 3 innovation timeline 4 key facts 5 references 6 external links 7 see also overview edit vis online feasibility platform streamlines the process of finding and assessing researchers and research centers for clinical trials using public and private data together with advanced analytics . the platform uses an intuitive highly navigable graphical interface to facilitate finding active research centers in a given therapeutic area at the country state city or postal code level . the vis platform also allows research centers to provide technical information about their expertise and internal capabilities in conducting trials within specific disease areas and networking features enable trial planners and research centers to connect immediately . one of the main benefits of the platform is that it obviates the need for repetitive and cumbersome feasibility questionnaires . headquartered in new york city vis has offices in brazil germany and india . vis provides up to date advanced analytics on clinical research infrastructure and personnel individual research centers investigator profiles curated patient demographics and public and private research center networks . examples include information about ongoing trials number of trials per center available patients and patient engagement levels number of patients enrolled in clinical research per 100 000 patients in a city or location . individual trial centers can display information about their expertise and capabilities including detailed information about their research staff aggregate patient demographics infrastructure capabilities and research as part of their vis profile . vis profile example novel location analytics showing the number of trials at site level and growth rate for all diseases in the top 50 countries . vis analytics cover over 400 000 disease specific research sites . a key feature is the novel combination of location analytics compiled by vis i.e. aggregate patient demographics and trial engagement metrics with site specific data provided by the research centers . vis integrates information from three primary data sources through collaborative analytics internal research research sites and investigators and 3rd party data . the company uses parsing algorithms natural language processing and pattern recognition to curate and harmonize data from public and private sources . all information is then continuously harmonized and integrated using proprietary semantic technologies to generate disease specific analytics . the data is then geo referenced and integrated with crowd sourced inputs from individual research centers . 1 in january 2014 inventiv health clinical a leading drug developer reported that it had analyzed data from 100 feasibility studies to determine the value of using vis analytics for trial feasibility . according to inventiv its assessment of vis s platform showed a reduction in mean feasibility time by 54 % . inventiv s senior vice president and general manager of its clinical trial recruitment services noted that its leveraging of the efficiencies were expected to continue noting that i n the next phase of development on the vis platform we ll accelerate our feasibility processes even more . 2 users of vis collaborative analytics include pharmaceutical biotechnology medical device and diagnostic companies academic and government institutions contract research organizations cros and other organizations around the world engaged in clinical trials . vis was featured at tedmed in april 2013 as part of the hive . 3 4 on may 7th 2013 vis announced a partnership with the biotechnology industry organization bio to map the pediatric populations of multiple countries to facilitate pediatric research . the release noted that such research was often frustrated by the complexity of finding patients for such research even though about 60 % of the disease burden for high priority conditions is borne by children . 5 vis has also announced strategic collaborations with the accreditation agency aahrpp the association for the accreditation of human research protection programs and with one of the largest networks of clinical trial research sites brany biomedical research alliance of new york . 6 in august 2013 the alliance for clinical research excellence and safety acres announced a collaboration with vis in the launch of a global clinical research network technology platform . 6 vis research was founded by dr. fabio thiers who used to be the director of mit s strategic global trials research program . 7 technology edit vis is the only feasibility platform that enables location selection site investigator selection and engagement in one sitting . in so doing it greatly facilitates clinical trial planning . it also provides the first and only fully integrated map of global clinical research activity and infrastructure . this is done through the use of proprietary algorithms that collect and harmonize disaggregated clinical research information about ongoing research and local demographics globally . in this way vis maps country state city and local disease specific patient populations ongoing research activity research infrastructure and investigators all within a specific disease and region . vis analytics include the following location analytics provides an interactive way to view location specific information about patients research activity infrastructure and research personnel for each disease covered location profile provides detailed analytics and scoring metrics main research centers and top research locations about each location advanced center analytics enables instantaneous access to over 400 000 disease specific sites all over the world investigator analytics enables trial planners to extensively evaluate and compare both general and disease specific investigator information . network analytics makes it possible to quickly determine the aggregate capabilities of research center networks and access their shared infrastructure partner profile provides analytics about site networks smos accreditation organizations and many others feasibility management enables the organization and management of research center evaluation and communication at scale innovation timeline edit 2003 2010 research on inefficiencies in drug development and the process of site identification and selection by fabio thiers md phd . at mit . key findings were published in nature . 7 2010 2012 2010 the vis research institute was founded . initial work included developing advanced tools and procedures for harvesting and curating structured data about ongoing clinical research and center capabilities . 2011 vis began data collection and harmonization . 2012 analytics developed including location analytics center analytics and center profile jun 2012 launch of the vis platform for collaborative analytics 2013 present jan new social collaboration features such as share messaging and network updates mar location scoring to rank countries states and cities on patient population research activity infrastructure and investigators apr new investigator profile to enable investigators to create and share a structured online profile may new partner profile page to provide analytics about smos disease specific networks accreditation networks and others jun new coverage for melanoma headache atopic dermatitis and filter by pediatric population key facts edit 178 countries 400 000 disease specific centers 360 000 investigators 1 376 epidemiological databases 148 366 trials 1 165 729 trial at site level 59 000 institutional profiles 85 % of feasibility questions 67 diseases with feasibility instrument 69 diseases with patient mapping 80 % of clinical trial collaborations 7 900 fda inspections references edit http visresearch.com servlet controller cmd trialplanners http www.prnewswire.com news releases inventiv health leverages advanced digital technology to slash the time required to conduct feasibility studies 241640041.html archived copy pdf . archived from the original pdf on august 12 2013 . retrieved january 25 2014 . archived copy pdf . archived from the original pdf on may 13 2013 . retrieved january 25 2014 . http online.wsj.com article pr co 20130507 911627.html mod googlenews wsj a b http www.visresearch.org servlet controller cmd news a b http www.nature.com nrd journal v7 n1 suppinfo nrd2441.html external links edit vis research ifapp world publication valor economico article vis research news aahrpp and vis research collaborate to protect research participants advance quality research brany and vis research institute partnership to streamline feasibility assessment for clinical trials trial site feasibility platform looks to end onerous paper questionnaires see also edit medical research biomedical informatics biomedical scientist biomedical technology biomedicine human experimentation medical research scientist medical scientist training program pharmaceutical company preclinical imaging title 21 of the code of federal regulations usa translational research list of pharmaceutical companies clinical trial management system retrieved from https en.wikipedia.org w index.php title vis research & oldid 742492132 categories pharmaceutical companies of the united statesamerican companies established in 2010pharmacies of the united statescompanies based in new york2010 establishments in new yorkpharmaceutical companies established in 2010hidden categories articles created via the article wizard navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page print export create a bookdownload as pdfprintable version languages add links this page was last modified on 4 october 2016 at 01 33 . text is available under the creative commons attribution sharealike license ; additional terms may apply . by using this site you agree to the terms of use and privacy policy . wikipedia is a registered trademark of the wikimedia foundation inc. a non profit organization . privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view